カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のトロンボポエチン受容体アゴニスト市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Thrombopoietin Receptor Agonist Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19661）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19661
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のトロンボポエチン受容体アゴニスト市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

トロンボポエチン受容体アゴニスト市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のトロンボポエチン受容体アゴニストの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

トロンボポエチン受容体アゴニスト市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ペプチド剤、低分子剤

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他

世界のトロンボポエチン受容体アゴニスト市場の主要な市場プレーヤーは以下のとおりです。
・Amgen、Novartis、Rigel Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、トロンボポエチン受容体アゴニスト製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なトロンボポエチン受容体アゴニストメーカーの企業概要、2019年～2022年までのトロンボポエチン受容体アゴニストの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なトロンボポエチン受容体アゴニストメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別トロンボポエチン受容体アゴニストの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのトロンボポエチン受容体アゴニストの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのトロンボポエチン受容体アゴニスト市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびトロンボポエチン受容体アゴニストの産業チェーンを掲載しています。
・第13、14、15章では、トロンボポエチン受容体アゴニストの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- トロンボポエチン受容体アゴニストの概要
- 種類別分析（2017年vs2021年vs2028年）：ペプチド剤、低分子剤
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他
- 世界のトロンボポエチン受容体アゴニスト市場規模・予測
- 世界のトロンボポエチン受容体アゴニスト生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Amgen、Novartis、Rigel Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ペプチド剤、低分子剤
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局、その他
・トロンボポエチン受容体アゴニストの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・トロンボポエチン受容体アゴニストのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・トロンボポエチン受容体アゴニストのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・トロンボポエチン受容体アゴニストの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・トロンボポエチン受容体アゴニストの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Thrombopoietin Receptor Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Thrombopoietin Receptor Agonist market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacy accounting for % of the Thrombopoietin Receptor Agonist global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peptide Agent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Thrombopoietin Receptor Agonist include Amgen, Novartis, Rigel Pharmaceuticals, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Thrombopoietin Receptor Agonist market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peptide Agent
Small Molecule Agent
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
The key market players for global Thrombopoietin Receptor Agonist market are listed below:
Amgen
Novartis
Rigel Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Thrombopoietin Receptor Agonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Thrombopoietin Receptor Agonist, with price, sales, revenue and global market share of Thrombopoietin Receptor Agonist from 2019 to 2022.
Chapter 3, the Thrombopoietin Receptor Agonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Thrombopoietin Receptor Agonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Thrombopoietin Receptor Agonist market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Thrombopoietin Receptor Agonist.
Chapter 13, 14, and 15, to describe Thrombopoietin Receptor Agonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Thrombopoietin Receptor Agonist Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Thrombopoietin Receptor Agonist Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Peptide Agent
1.2.3 Small Molecule Agent
1.3 Market Analysis by Application
1.3.1 Overview: Global Thrombopoietin Receptor Agonist Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Thrombopoietin Receptor Agonist Market Size & Forecast
1.4.1 Global Thrombopoietin Receptor Agonist Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Thrombopoietin Receptor Agonist Sales in Volume (2017-2028)
1.4.3 Global Thrombopoietin Receptor Agonist Price (2017-2028)
1.5 Global Thrombopoietin Receptor Agonist Production Capacity Analysis
1.5.1 Global Thrombopoietin Receptor Agonist Total Production Capacity (2017-2028)
1.5.2 Global Thrombopoietin Receptor Agonist Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Thrombopoietin Receptor Agonist Market Drivers
1.6.2 Thrombopoietin Receptor Agonist Market Restraints
1.6.3 Thrombopoietin Receptor Agonist Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Thrombopoietin Receptor Agonist Product and Services
2.1.4 Amgen Thrombopoietin Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Thrombopoietin Receptor Agonist Product and Services
2.2.4 Novartis Thrombopoietin Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Rigel Pharmaceuticals
2.3.1 Rigel Pharmaceuticals Details
2.3.2 Rigel Pharmaceuticals Major Business
2.3.3 Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Product and Services
2.3.4 Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Thrombopoietin Receptor Agonist Breakdown Data by Manufacturer
3.1 Global Thrombopoietin Receptor Agonist Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Thrombopoietin Receptor Agonist Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Thrombopoietin Receptor Agonist
3.4 Market Concentration Rate
3.4.1 Top 3 Thrombopoietin Receptor Agonist Manufacturer Market Share in 2021
3.4.2 Top 6 Thrombopoietin Receptor Agonist Manufacturer Market Share in 2021
3.5 Global Thrombopoietin Receptor Agonist Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Thrombopoietin Receptor Agonist Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Thrombopoietin Receptor Agonist Market Size by Region
4.1.1 Global Thrombopoietin Receptor Agonist Sales in Volume by Region (2017-2028)
4.1.2 Global Thrombopoietin Receptor Agonist Revenue by Region (2017-2028)
4.2 North America Thrombopoietin Receptor Agonist Revenue (2017-2028)
4.3 Europe Thrombopoietin Receptor Agonist Revenue (2017-2028)
4.4 Asia-Pacific Thrombopoietin Receptor Agonist Revenue (2017-2028)
4.5 South America Thrombopoietin Receptor Agonist Revenue (2017-2028)
4.6 Middle East and Africa Thrombopoietin Receptor Agonist Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Thrombopoietin Receptor Agonist Sales in Volume by Type (2017-2028)
5.2 Global Thrombopoietin Receptor Agonist Revenue by Type (2017-2028)
5.3 Global Thrombopoietin Receptor Agonist Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Thrombopoietin Receptor Agonist Sales in Volume by Application (2017-2028)
6.2 Global Thrombopoietin Receptor Agonist Revenue by Application (2017-2028)
6.3 Global Thrombopoietin Receptor Agonist Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Thrombopoietin Receptor Agonist Sales by Type (2017-2028)
7.2 North America Thrombopoietin Receptor Agonist Sales by Application (2017-2028)
7.3 North America Thrombopoietin Receptor Agonist Market Size by Country
7.3.1 North America Thrombopoietin Receptor Agonist Sales in Volume by Country (2017-2028)
7.3.2 North America Thrombopoietin Receptor Agonist Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Thrombopoietin Receptor Agonist Sales by Type (2017-2028)
8.2 Europe Thrombopoietin Receptor Agonist Sales by Application (2017-2028)
8.3 Europe Thrombopoietin Receptor Agonist Market Size by Country
8.3.1 Europe Thrombopoietin Receptor Agonist Sales in Volume by Country (2017-2028)
8.3.2 Europe Thrombopoietin Receptor Agonist Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Thrombopoietin Receptor Agonist Sales by Type (2017-2028)
9.2 Asia-Pacific Thrombopoietin Receptor Agonist Sales by Application (2017-2028)
9.3 Asia-Pacific Thrombopoietin Receptor Agonist Market Size by Region
9.3.1 Asia-Pacific Thrombopoietin Receptor Agonist Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Thrombopoietin Receptor Agonist Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Thrombopoietin Receptor Agonist Sales by Type (2017-2028)
10.2 South America Thrombopoietin Receptor Agonist Sales by Application (2017-2028)
10.3 South America Thrombopoietin Receptor Agonist Market Size by Country
10.3.1 South America Thrombopoietin Receptor Agonist Sales in Volume by Country (2017-2028)
10.3.2 South America Thrombopoietin Receptor Agonist Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Thrombopoietin Receptor Agonist Sales by Type (2017-2028)
11.2 Middle East & Africa Thrombopoietin Receptor Agonist Sales by Application (2017-2028)
11.3 Middle East & Africa Thrombopoietin Receptor Agonist Market Size by Country
11.3.1 Middle East & Africa Thrombopoietin Receptor Agonist Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Thrombopoietin Receptor Agonist Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Thrombopoietin Receptor Agonist and Key Manufacturers
12.2 Manufacturing Costs Percentage of Thrombopoietin Receptor Agonist
12.3 Thrombopoietin Receptor Agonist Production Process
12.4 Thrombopoietin Receptor Agonist Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Thrombopoietin Receptor Agonist Typical Distributors
13.3 Thrombopoietin Receptor Agonist Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Thrombopoietin Receptor Agonist Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Thrombopoietin Receptor Agonist Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Thrombopoietin Receptor Agonist Product and Services
Table 6. Amgen Thrombopoietin Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Thrombopoietin Receptor Agonist Product and Services
Table 10. Novartis Thrombopoietin Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Rigel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Rigel Pharmaceuticals Major Business
Table 13. Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Product and Services
Table 14. Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Thrombopoietin Receptor Agonist Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global Thrombopoietin Receptor Agonist Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Thrombopoietin Receptor Agonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Thrombopoietin Receptor Agonist Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Thrombopoietin Receptor Agonist Production Site of Key Manufacturer
Table 20. Thrombopoietin Receptor Agonist New Entrant and Capacity Expansion Plans
Table 21. Thrombopoietin Receptor Agonist Mergers & Acquisitions in the Past Five Years
Table 22. Global Thrombopoietin Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 23. Global Thrombopoietin Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 24. Global Thrombopoietin Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Thrombopoietin Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 27. Global Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 28. Global Thrombopoietin Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Thrombopoietin Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Thrombopoietin Receptor Agonist Price by Type (2017-2022) & (US$/Unit)
Table 31. Global Thrombopoietin Receptor Agonist Price by Type (2023-2028) & (US$/Unit)
Table 32. Global Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 33. Global Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 34. Global Thrombopoietin Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Thrombopoietin Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Thrombopoietin Receptor Agonist Price by Application (2017-2022) & (US$/Unit)
Table 37. Global Thrombopoietin Receptor Agonist Price by Application (2023-2028) & (US$/Unit)
Table 38. North America Thrombopoietin Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 39. North America Thrombopoietin Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 40. North America Thrombopoietin Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Thrombopoietin Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 43. North America Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 44. North America Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 45. North America Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 46. Europe Thrombopoietin Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 47. Europe Thrombopoietin Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 48. Europe Thrombopoietin Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Thrombopoietin Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 51. Europe Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 52. Europe Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 53. Europe Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Thrombopoietin Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Thrombopoietin Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 62. South America Thrombopoietin Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 63. South America Thrombopoietin Receptor Agonist Sales by Country (2023-2028) & (K Units)
Table 64. South America Thrombopoietin Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Thrombopoietin Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 67. South America Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 68. South America Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 69. South America Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa Thrombopoietin Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Thrombopoietin Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa Thrombopoietin Receptor Agonist Sales by Application (2023-2028) & (K Units)
Table 78. Thrombopoietin Receptor Agonist Raw Material
Table 79. Key Manufacturers of Thrombopoietin Receptor Agonist Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Thrombopoietin Receptor Agonist Typical Distributors
Table 83. Thrombopoietin Receptor Agonist Typical Customers
List of Figures
Figure 1. Thrombopoietin Receptor Agonist Picture
Figure 2. Global Thrombopoietin Receptor Agonist Revenue Market Share by Type in 2021
Figure 3. Peptide Agent
Figure 4. Small Molecule Agent
Figure 5. Global Thrombopoietin Receptor Agonist Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Others
Figure 10. Global Thrombopoietin Receptor Agonist Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Thrombopoietin Receptor Agonist Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Thrombopoietin Receptor Agonist Sales (2017-2028) & (K Units)
Figure 13. Global Thrombopoietin Receptor Agonist Price (2017-2028) & (US$/Unit)
Figure 14. Global Thrombopoietin Receptor Agonist Production Capacity (2017-2028) & (K Units)
Figure 15. Global Thrombopoietin Receptor Agonist Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Thrombopoietin Receptor Agonist Market Drivers
Figure 17. Thrombopoietin Receptor Agonist Market Restraints
Figure 18. Thrombopoietin Receptor Agonist Market Trends
Figure 19. Global Thrombopoietin Receptor Agonist Sales Market Share by Manufacturer in 2021
Figure 20. Global Thrombopoietin Receptor Agonist Revenue Market Share by Manufacturer in 2021
Figure 21. Thrombopoietin Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Thrombopoietin Receptor Agonist Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Thrombopoietin Receptor Agonist Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Thrombopoietin Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 25. Global Thrombopoietin Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 26. North America Thrombopoietin Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 27. Europe Thrombopoietin Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Thrombopoietin Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 29. South America Thrombopoietin Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Thrombopoietin Receptor Agonist Revenue (2017-2028) & (USD Million)
Figure 31. Global Thrombopoietin Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 32. Global Thrombopoietin Receptor Agonist Revenue Market Share by Type (2017-2028)
Figure 33. Global Thrombopoietin Receptor Agonist Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 35. Global Thrombopoietin Receptor Agonist Revenue Market Share by Application (2017-2028)
Figure 36. Global Thrombopoietin Receptor Agonist Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Thrombopoietin Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 38. North America Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 39. North America Thrombopoietin Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 40. North America Thrombopoietin Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 41. United States Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Thrombopoietin Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 45. Europe Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 46. Europe Thrombopoietin Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 47. Europe Thrombopoietin Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 48. Germany Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Thrombopoietin Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Thrombopoietin Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Thrombopoietin Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 57. China Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Thrombopoietin Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 64. South America Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 65. South America Thrombopoietin Receptor Agonist Sales Market Share by Country (2017-2028)
Figure 66. South America Thrombopoietin Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Thrombopoietin Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Thrombopoietin Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Thrombopoietin Receptor Agonist Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Thrombopoietin Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Thrombopoietin Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Thrombopoietin Receptor Agonist in 2021
Figure 78. Manufacturing Process Analysis of Thrombopoietin Receptor Agonist
Figure 79. Thrombopoietin Receptor Agonist Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のプロゲステロン受容体アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場2022年：市場規模予測（～2028年）
  • 世界のアデノシン受容体A3市場2022年：市場規模予測（～2028年）
  • 世界の代謝型グルタミン酸受容体1型（mGluR1）市場2022年：市場規模予測（～2028年）
  • 世界のGnRH受容体拮抗薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19661 )"世界のトロンボポエチン受容体アゴニスト市場2022年：市場規模予測（～2028年）" (英文：Global Thrombopoietin Receptor Agonist Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。